Trial Outcomes & Findings for Consumer Perceptions of Cannabidiol (CBD) Health Claims (NCT NCT06069713)
NCT ID: NCT06069713
Last Updated: 2026-03-20
Results Overview
The primary outcome is consumer perception of the claims in the ads (n=55) and whether perceptions of prohibited claims vary by CBD use status. After viewing each of the 5 assigned ads participants will respond to six items that assess their perception of the prohibited claims made in the ads, including 1) drug effect 2) FDA approved/ endorsed 3) dietary supplement 4) food additive 5) false/misleading (scientific) and 6) false/misleading (targeting youth). The Study Team will use a 5-point response scale, (1) Not at all to (5) Extremely to assess perception of each prohibited claim type. For each use status group, the Study Team will report the overall mean score (all ads together) for each claim type to indicate if perception of prohibited claims differed by use status.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
3504 participants
Primary outcome timeframe
Minute 15
Results posted on
2026-03-20
Participant Flow
21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
Participant milestones
| Measure |
Panel 1
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 2
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 3
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 4
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 5
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 6
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 7
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 8
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 9
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 10
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 11
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Overall Study
STARTED
|
307
|
311
|
307
|
305
|
334
|
319
|
292
|
301
|
346
|
354
|
328
|
|
Overall Study
COMPLETED
|
262
|
281
|
276
|
262
|
289
|
280
|
253
|
266
|
302
|
312
|
293
|
|
Overall Study
NOT COMPLETED
|
45
|
30
|
31
|
43
|
45
|
39
|
39
|
35
|
44
|
42
|
35
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
Baseline characteristics by cohort
| Measure |
Panel 1
n=262 Participants
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 2
n=281 Participants
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 3
n=276 Participants
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 4
n=262 Participants
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 5
n=289 Participants
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 6
n=280 Participants
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 7
n=253 Participants
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 8
n=266 Participants
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 9
n=302 Participants
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 10
n=312 Participants
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Panel 11
n=293 Participants
This panel consists of 5 photos that were found in CBD retail assessments. Photos were coded as at least one of six FDA prohibited claim types or contained product descriptors that may be potentially misleading to consumers. Photos did not differ substantially between panels and panels were only used to reduce participant burden, as 55 photos were to be included in the survey
|
Total
n=3076 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Age, Continuous
|
42.4 years
STANDARD_DEVIATION 13.1 • n=154 Participants
|
43.8 years
STANDARD_DEVIATION 12.8 • n=151 Participants
|
43.5 years
STANDARD_DEVIATION 13.8 • n=305 Participants
|
43.9 years
STANDARD_DEVIATION 13.7 • n=104 Participants
|
43.9 years
STANDARD_DEVIATION 14.3 • n=22 Participants
|
43.2 years
STANDARD_DEVIATION 13.1 • n=21 Participants
|
43.7 years
STANDARD_DEVIATION 13.8 • n=26 Participants
|
43.9 years
STANDARD_DEVIATION 13.3 • n=162 Participants
|
44.0 years
STANDARD_DEVIATION 13.4 • n=3 Participants
|
43.8 years
STANDARD_DEVIATION 14.0 • n=6 Participants
|
43.1 years
STANDARD_DEVIATION 13.5 • n=6 Participants
|
43.6 years
STANDARD_DEVIATION 13.5 • n=39 Participants
|
|
Sex/Gender, Customized
Current Gender Male
|
121 Participants
n=154 Participants
|
119 Participants
n=151 Participants
|
121 Participants
n=305 Participants
|
113 Participants
n=104 Participants
|
121 Participants
n=22 Participants
|
131 Participants
n=21 Participants
|
105 Participants
n=26 Participants
|
119 Participants
n=162 Participants
|
133 Participants
n=3 Participants
|
142 Participants
n=6 Participants
|
128 Participants
n=6 Participants
|
1353 Participants
n=39 Participants
|
|
Sex/Gender, Customized
Current Gender Female
|
132 Participants
n=154 Participants
|
156 Participants
n=151 Participants
|
146 Participants
n=305 Participants
|
142 Participants
n=104 Participants
|
159 Participants
n=22 Participants
|
143 Participants
n=21 Participants
|
142 Participants
n=26 Participants
|
140 Participants
n=162 Participants
|
157 Participants
n=3 Participants
|
159 Participants
n=6 Participants
|
156 Participants
n=6 Participants
|
1632 Participants
n=39 Participants
|
|
Sex/Gender, Customized
Current Gender Transgender
|
1 Participants
n=154 Participants
|
2 Participants
n=151 Participants
|
3 Participants
n=305 Participants
|
2 Participants
n=104 Participants
|
0 Participants
n=22 Participants
|
1 Participants
n=21 Participants
|
1 Participants
n=26 Participants
|
2 Participants
n=162 Participants
|
3 Participants
n=3 Participants
|
2 Participants
n=6 Participants
|
1 Participants
n=6 Participants
|
18 Participants
n=39 Participants
|
|
Sex/Gender, Customized
None of the Above Genders
|
1 Participants
n=154 Participants
|
0 Participants
n=151 Participants
|
0 Participants
n=305 Participants
|
1 Participants
n=104 Participants
|
3 Participants
n=22 Participants
|
1 Participants
n=21 Participants
|
2 Participants
n=26 Participants
|
4 Participants
n=162 Participants
|
3 Participants
n=3 Participants
|
2 Participants
n=6 Participants
|
2 Participants
n=6 Participants
|
19 Participants
n=39 Participants
|
|
Sex/Gender, Customized
Did not answer
|
7 Participants
n=154 Participants
|
4 Participants
n=151 Participants
|
6 Participants
n=305 Participants
|
4 Participants
n=104 Participants
|
6 Participants
n=22 Participants
|
4 Participants
n=21 Participants
|
3 Participants
n=26 Participants
|
1 Participants
n=162 Participants
|
6 Participants
n=3 Participants
|
7 Participants
n=6 Participants
|
6 Participants
n=6 Participants
|
54 Participants
n=39 Participants
|
|
Sex/Gender, Customized
Sex assigned at birth Male
|
122 Participants
n=154 Participants
|
119 Participants
n=151 Participants
|
124 Participants
n=305 Participants
|
114 Participants
n=104 Participants
|
125 Participants
n=22 Participants
|
131 Participants
n=21 Participants
|
108 Participants
n=26 Participants
|
122 Participants
n=162 Participants
|
134 Participants
n=3 Participants
|
145 Participants
n=6 Participants
|
128 Participants
n=6 Participants
|
1372 Participants
n=39 Participants
|
|
Sex/Gender, Customized
Sex assigned at birth Female
|
134 Participants
n=154 Participants
|
157 Participants
n=151 Participants
|
146 Participants
n=305 Participants
|
143 Participants
n=104 Participants
|
157 Participants
n=22 Participants
|
144 Participants
n=21 Participants
|
142 Participants
n=26 Participants
|
142 Participants
n=162 Participants
|
160 Participants
n=3 Participants
|
160 Participants
n=6 Participants
|
155 Participants
n=6 Participants
|
1640 Participants
n=39 Participants
|
|
Sex/Gender, Customized
Sex assigned at birth Did not answer
|
6 Participants
n=154 Participants
|
5 Participants
n=151 Participants
|
6 Participants
n=305 Participants
|
5 Participants
n=104 Participants
|
7 Participants
n=22 Participants
|
5 Participants
n=21 Participants
|
3 Participants
n=26 Participants
|
2 Participants
n=162 Participants
|
8 Participants
n=3 Participants
|
7 Participants
n=6 Participants
|
10 Participants
n=6 Participants
|
64 Participants
n=39 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
44 Participants
n=154 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
34 Participants
n=151 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
49 Participants
n=305 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
29 Participants
n=104 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
51 Participants
n=22 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
26 Participants
n=21 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
36 Participants
n=26 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
36 Participants
n=162 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
39 Participants
n=3 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
38 Participants
n=6 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
34 Participants
n=6 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
416 Participants
n=39 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=154 Participants
|
3 Participants
n=151 Participants
|
2 Participants
n=305 Participants
|
0 Participants
n=104 Participants
|
0 Participants
n=22 Participants
|
3 Participants
n=21 Participants
|
1 Participants
n=26 Participants
|
2 Participants
n=162 Participants
|
2 Participants
n=3 Participants
|
4 Participants
n=6 Participants
|
0 Participants
n=6 Participants
|
17 Participants
n=39 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
218 Participants
n=154 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
247 Participants
n=151 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
227 Participants
n=305 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
233 Participants
n=104 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
238 Participants
n=22 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
254 Participants
n=21 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
217 Participants
n=26 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
230 Participants
n=162 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
263 Participants
n=3 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
274 Participants
n=6 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
259 Participants
n=6 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
2660 Participants
n=39 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=154 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
0 Participants
n=151 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
0 Participants
n=305 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
0 Participants
n=104 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
0 Participants
n=22 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
0 Participants
n=21 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
0 Participants
n=26 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
0 Participants
n=162 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
0 Participants
n=3 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
0 Participants
n=6 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
0 Participants
n=6 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
0 Participants
n=39 Participants • 21 people were consented but dropped out of the study prior to being assigned a panel. 428 people were excluded from analysis due to poor data quality: The excluded ppts did not meet sufficient completion criteria. Participants must have met both of the following criteria to be included in the study: 1) at least 75% of the outcome variables answered (not skipped) and 2) survey completion time of \> 5min
|
|
Race (NIH/OMB)
Asian
|
11 Participants
n=154 Participants
|
15 Participants
n=151 Participants
|
6 Participants
n=305 Participants
|
15 Participants
n=104 Participants
|
8 Participants
n=22 Participants
|
7 Participants
n=21 Participants
|
7 Participants
n=26 Participants
|
10 Participants
n=162 Participants
|
14 Participants
n=3 Participants
|
15 Participants
n=6 Participants
|
10 Participants
n=6 Participants
|
118 Participants
n=39 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
2 Participants
n=154 Participants
|
1 Participants
n=151 Participants
|
1 Participants
n=305 Participants
|
0 Participants
n=104 Participants
|
0 Participants
n=22 Participants
|
1 Participants
n=21 Participants
|
0 Participants
n=26 Participants
|
0 Participants
n=162 Participants
|
2 Participants
n=3 Participants
|
2 Participants
n=6 Participants
|
0 Participants
n=6 Participants
|
9 Participants
n=39 Participants
|
|
Race (NIH/OMB)
Black or African American
|
35 Participants
n=154 Participants
|
26 Participants
n=151 Participants
|
34 Participants
n=305 Participants
|
31 Participants
n=104 Participants
|
46 Participants
n=22 Participants
|
37 Participants
n=21 Participants
|
33 Participants
n=26 Participants
|
39 Participants
n=162 Participants
|
40 Participants
n=3 Participants
|
48 Participants
n=6 Participants
|
45 Participants
n=6 Participants
|
414 Participants
n=39 Participants
|
|
Race (NIH/OMB)
White
|
195 Participants
n=154 Participants
|
213 Participants
n=151 Participants
|
199 Participants
n=305 Participants
|
195 Participants
n=104 Participants
|
202 Participants
n=22 Participants
|
214 Participants
n=21 Participants
|
187 Participants
n=26 Participants
|
190 Participants
n=162 Participants
|
220 Participants
n=3 Participants
|
216 Participants
n=6 Participants
|
211 Participants
n=6 Participants
|
2242 Participants
n=39 Participants
|
|
Race (NIH/OMB)
More than one race
|
8 Participants
n=154 Participants
|
13 Participants
n=151 Participants
|
15 Participants
n=305 Participants
|
13 Participants
n=104 Participants
|
20 Participants
n=22 Participants
|
10 Participants
n=21 Participants
|
15 Participants
n=26 Participants
|
16 Participants
n=162 Participants
|
12 Participants
n=3 Participants
|
12 Participants
n=6 Participants
|
16 Participants
n=6 Participants
|
150 Participants
n=39 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
11 Participants
n=154 Participants
|
10 Participants
n=151 Participants
|
19 Participants
n=305 Participants
|
8 Participants
n=104 Participants
|
13 Participants
n=22 Participants
|
8 Participants
n=21 Participants
|
10 Participants
n=26 Participants
|
9 Participants
n=162 Participants
|
12 Participants
n=3 Participants
|
15 Participants
n=6 Participants
|
11 Participants
n=6 Participants
|
126 Participants
n=39 Participants
|
|
Education Level
Less than High School
|
15 Participants
n=154 Participants
|
13 Participants
n=151 Participants
|
26 Participants
n=305 Participants
|
17 Participants
n=104 Participants
|
23 Participants
n=22 Participants
|
20 Participants
n=21 Participants
|
13 Participants
n=26 Participants
|
15 Participants
n=162 Participants
|
13 Participants
n=3 Participants
|
19 Participants
n=6 Participants
|
24 Participants
n=6 Participants
|
198 Participants
n=39 Participants
|
|
Education Level
HS graduate or equivalent
|
43 Participants
n=154 Participants
|
56 Participants
n=151 Participants
|
48 Participants
n=305 Participants
|
41 Participants
n=104 Participants
|
53 Participants
n=22 Participants
|
49 Participants
n=21 Participants
|
33 Participants
n=26 Participants
|
34 Participants
n=162 Participants
|
55 Participants
n=3 Participants
|
48 Participants
n=6 Participants
|
54 Participants
n=6 Participants
|
514 Participants
n=39 Participants
|
|
Education Level
Vocational/tech school/some college/associates
|
98 Participants
n=154 Participants
|
87 Participants
n=151 Participants
|
99 Participants
n=305 Participants
|
104 Participants
n=104 Participants
|
115 Participants
n=22 Participants
|
109 Participants
n=21 Participants
|
89 Participants
n=26 Participants
|
94 Participants
n=162 Participants
|
115 Participants
n=3 Participants
|
119 Participants
n=6 Participants
|
97 Participants
n=6 Participants
|
1126 Participants
n=39 Participants
|
|
Education Level
Bachelor's Degree
|
70 Participants
n=154 Participants
|
72 Participants
n=151 Participants
|
57 Participants
n=305 Participants
|
63 Participants
n=104 Participants
|
55 Participants
n=22 Participants
|
66 Participants
n=21 Participants
|
74 Participants
n=26 Participants
|
75 Participants
n=162 Participants
|
65 Participants
n=3 Participants
|
89 Participants
n=6 Participants
|
77 Participants
n=6 Participants
|
763 Participants
n=39 Participants
|
|
Education Level
Post grad study/professional degree
|
36 Participants
n=154 Participants
|
53 Participants
n=151 Participants
|
46 Participants
n=305 Participants
|
37 Participants
n=104 Participants
|
43 Participants
n=22 Participants
|
36 Participants
n=21 Participants
|
44 Participants
n=26 Participants
|
48 Participants
n=162 Participants
|
54 Participants
n=3 Participants
|
37 Participants
n=6 Participants
|
41 Participants
n=6 Participants
|
475 Participants
n=39 Participants
|
|
SES
Less than $10,000
|
9 Participants
n=154 Participants
|
9 Participants
n=151 Participants
|
19 Participants
n=305 Participants
|
9 Participants
n=104 Participants
|
17 Participants
n=22 Participants
|
14 Participants
n=21 Participants
|
6 Participants
n=26 Participants
|
16 Participants
n=162 Participants
|
12 Participants
n=3 Participants
|
18 Participants
n=6 Participants
|
15 Participants
n=6 Participants
|
144 Participants
n=39 Participants
|
|
SES
$10,000 to less than $25,000
|
20 Participants
n=154 Participants
|
42 Participants
n=151 Participants
|
32 Participants
n=305 Participants
|
32 Participants
n=104 Participants
|
27 Participants
n=22 Participants
|
33 Participants
n=21 Participants
|
25 Participants
n=26 Participants
|
33 Participants
n=162 Participants
|
34 Participants
n=3 Participants
|
30 Participants
n=6 Participants
|
35 Participants
n=6 Participants
|
343 Participants
n=39 Participants
|
|
SES
$25,000 to less than $50,000
|
44 Participants
n=154 Participants
|
48 Participants
n=151 Participants
|
51 Participants
n=305 Participants
|
60 Participants
n=104 Participants
|
64 Participants
n=22 Participants
|
61 Participants
n=21 Participants
|
52 Participants
n=26 Participants
|
49 Participants
n=162 Participants
|
70 Participants
n=3 Participants
|
67 Participants
n=6 Participants
|
64 Participants
n=6 Participants
|
630 Participants
n=39 Participants
|
|
SES
$50,000 to less than $75,000
|
59 Participants
n=154 Participants
|
54 Participants
n=151 Participants
|
60 Participants
n=305 Participants
|
47 Participants
n=104 Participants
|
56 Participants
n=22 Participants
|
59 Participants
n=21 Participants
|
40 Participants
n=26 Participants
|
46 Participants
n=162 Participants
|
50 Participants
n=3 Participants
|
50 Participants
n=6 Participants
|
52 Participants
n=6 Participants
|
573 Participants
n=39 Participants
|
|
SES
$75,000 to less than $100,000
|
37 Participants
n=154 Participants
|
43 Participants
n=151 Participants
|
33 Participants
n=305 Participants
|
31 Participants
n=104 Participants
|
52 Participants
n=22 Participants
|
40 Participants
n=21 Participants
|
47 Participants
n=26 Participants
|
39 Participants
n=162 Participants
|
31 Participants
n=3 Participants
|
43 Participants
n=6 Participants
|
42 Participants
n=6 Participants
|
438 Participants
n=39 Participants
|
|
SES
More than $100,000
|
93 Participants
n=154 Participants
|
85 Participants
n=151 Participants
|
81 Participants
n=305 Participants
|
83 Participants
n=104 Participants
|
73 Participants
n=22 Participants
|
73 Participants
n=21 Participants
|
83 Participants
n=26 Participants
|
83 Participants
n=162 Participants
|
105 Participants
n=3 Participants
|
104 Participants
n=6 Participants
|
85 Participants
n=6 Participants
|
948 Participants
n=39 Participants
|
|
State Cannabis policy
Medical and Recreational states
|
151 Participants
n=154 Participants
|
149 Participants
n=151 Participants
|
135 Participants
n=305 Participants
|
145 Participants
n=104 Participants
|
163 Participants
n=22 Participants
|
155 Participants
n=21 Participants
|
143 Participants
n=26 Participants
|
143 Participants
n=162 Participants
|
161 Participants
n=3 Participants
|
172 Participants
n=6 Participants
|
169 Participants
n=6 Participants
|
1686 Participants
n=39 Participants
|
|
State Cannabis policy
Medical only states
|
48 Participants
n=154 Participants
|
62 Participants
n=151 Participants
|
71 Participants
n=305 Participants
|
54 Participants
n=104 Participants
|
53 Participants
n=22 Participants
|
57 Participants
n=21 Participants
|
54 Participants
n=26 Participants
|
60 Participants
n=162 Participants
|
62 Participants
n=3 Participants
|
62 Participants
n=6 Participants
|
56 Participants
n=6 Participants
|
639 Participants
n=39 Participants
|
|
State Cannabis policy
CBD/Low THC states
|
54 Participants
n=154 Participants
|
61 Participants
n=151 Participants
|
62 Participants
n=305 Participants
|
58 Participants
n=104 Participants
|
65 Participants
n=22 Participants
|
59 Participants
n=21 Participants
|
52 Participants
n=26 Participants
|
53 Participants
n=162 Participants
|
72 Participants
n=3 Participants
|
68 Participants
n=6 Participants
|
59 Participants
n=6 Participants
|
663 Participants
n=39 Participants
|
|
State Cannabis policy
No cannabis access states
|
9 Participants
n=154 Participants
|
9 Participants
n=151 Participants
|
8 Participants
n=305 Participants
|
5 Participants
n=104 Participants
|
8 Participants
n=22 Participants
|
9 Participants
n=21 Participants
|
4 Participants
n=26 Participants
|
10 Participants
n=162 Participants
|
7 Participants
n=3 Participants
|
10 Participants
n=6 Participants
|
9 Participants
n=6 Participants
|
88 Participants
n=39 Participants
|
PRIMARY outcome
Timeframe: Minute 15Population: participants were pre-specified to be reported "per CBD user status"
The primary outcome is consumer perception of the claims in the ads (n=55) and whether perceptions of prohibited claims vary by CBD use status. After viewing each of the 5 assigned ads participants will respond to six items that assess their perception of the prohibited claims made in the ads, including 1) drug effect 2) FDA approved/ endorsed 3) dietary supplement 4) food additive 5) false/misleading (scientific) and 6) false/misleading (targeting youth). The Study Team will use a 5-point response scale, (1) Not at all to (5) Extremely to assess perception of each prohibited claim type. For each use status group, the Study Team will report the overall mean score (all ads together) for each claim type to indicate if perception of prohibited claims differed by use status.
Outcome measures
| Measure |
Current CBD Users
n=1008 Participants
Participants who have used CBD in the last month
|
Ever CBD Users
n=1053 Participants
Participants who have used CBD before, but not in the last month
|
Non CBD Users
n=1015 Participants
Participants who have never used CBD
|
|---|---|---|---|
|
Perceived Claim Scores
Drug Effect
|
2.96 score on a scale
Standard Error 0.02
|
2.81 score on a scale
Standard Error 0.02
|
2.71 score on a scale
Standard Error 0.03
|
|
Perceived Claim Scores
FDA
|
2.03 score on a scale
Standard Error 0.03
|
1.76 score on a scale
Standard Error 0.02
|
1.64 score on a scale
Standard Error 0.02
|
|
Perceived Claim Scores
Dietary Supplement
|
2.44 score on a scale
Standard Error 0.02
|
2.23 score on a scale
Standard Error 0.02
|
2.18 score on a scale
Standard Error 0.02
|
|
Perceived Claim Scores
Food Additive
|
2.32 score on a scale
Standard Error 0.03
|
2.06 score on a scale
Standard Error 0.02
|
2.00 score on a scale
Standard Error 0.02
|
|
Perceived Claim Scores
False and Misleading (Science)
|
2.57 score on a scale
Standard Error 0.03
|
2.27 score on a scale
Standard Error 0.02
|
2.11 score on a scale
Standard Error 0.02
|
|
Perceived Claim Scores
False and Misleading (Youth)
|
2.68 score on a scale
Standard Error 0.02
|
2.55 score on a scale
Standard Error 0.02
|
2.57 score on a scale
Standard Error 0.02
|
SECONDARY outcome
Timeframe: Minute 15For each ad that the participant views (n=5), the Participant will respond to a one-item measure that assesses the extent to which the participant perceives that CBD is safe to consume. Response options are on a 1 to 5 scale, with higher scores representing more perceived safety (i.e. 1- Not at all safe to 5- Extremely safe). For each use status group, the Study Team will report the mean score of perceived safety to indicate if the perceived safety of CBD in the advertisements differed by use status.
Outcome measures
| Measure |
Current CBD Users
n=1008 Participants
Participants who have used CBD in the last month
|
Ever CBD Users
n=1053 Participants
Participants who have used CBD before, but not in the last month
|
Non CBD Users
n=1015 Participants
Participants who have never used CBD
|
|---|---|---|---|
|
Perceived Product Safety Scores
|
3.34 score on a scale
Standard Error 0.02
|
3.11 score on a scale
Standard Error 0.02
|
2.92 score on a scale
Standard Error 0.03
|
SECONDARY outcome
Timeframe: Minute 15For each ad that the participant views (n=5), the Participant will respond to a one-item measure to assess the extent to which the ad makes CBD appealing to them. Response options are on a 1 to 5 scale, with higher scores representing more appeal (i.e. 1- Not at all appealing to 5- Extremely appealing). For each use status group, the Study Team will report the mean score of appeal to indicate if the appeal of CBD in the advertisements differed by use status.
Outcome measures
| Measure |
Current CBD Users
n=1008 Participants
Participants who have used CBD in the last month
|
Ever CBD Users
n=1053 Participants
Participants who have used CBD before, but not in the last month
|
Non CBD Users
n=1015 Participants
Participants who have never used CBD
|
|---|---|---|---|
|
Appeal Scores
|
2.82 score on a scale
Standard Error 0.02
|
2.42 score on a scale
Standard Error 0.02
|
1.81 score on a scale
Standard Error 0.02
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Minute 15Ten items will measure participants' perceptions about the possible effects of CBD. Response items are on a 1 to 5 scale, with higher scores representing more agreement with the stated effect (i.e. 1- Strongly disagree to 5- Strongly agree).
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: Minute 15Seventeen items will measure participants' perceived benefits of daily CBD use to treat various medical conditions. Response items are on a 1 to 4 scale (1-Worsen the condition; 2- No effect on the condition; 3-Improve the condition; 4- I don't know)
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: Minute 15One item will be used to measure non-user's willingness to try CBD. Response items are on a 1 to 5 scale, with higher scores representing more likelihood to try CBD (i.e. 1- Extremely Unlikely to 5- Extremely Likely)
Outcome measures
Outcome data not reported
Adverse Events
Current CBD Users
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Ever CBD Users
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Non CBD Users
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Olivia Horton MSW, MPH
Wake Forest University Health Sciences
Phone: 000.000.0000
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place